Published in J Oral Maxillofac Surg on May 01, 2004
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res (2011) 3.01
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res (2008) 2.42
Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg (2008) 2.25
Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med (2008) 1.85
Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract (2006) 1.84
Fracture risk remains reduced one year after discontinuation of risedronate. Osteoporos Int (2007) 1.79
Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis. J Bone Miner Res (2012) 1.73
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Res (2006) 1.71
Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases. Osteoporos Int (2009) 1.70
A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer (2010) 1.68
Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention. BMJ (2006) 1.67
Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int (2007) 1.64
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician (2014) 1.63
Osteonecrosis of the jaw in a patient on Denosumab. J Oral Maxillofac Surg (2010) 1.59
Risks and benefits of bisphosphonates. Br J Cancer (2008) 1.57
Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 (2007) 1.44
Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. J Inherit Metab Dis (2008) 1.41
Osteonecrosis of the jaw associated with ziv-aflibercept. J Gastrointest Oncol (2016) 1.39
Epidemiology and pathogenesis of osteonecrosis of the jaw. Nat Rev Rheumatol (2011) 1.35
Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res (2011) 1.32
Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. J Bone Miner Metab (2009) 1.29
Successful treatment of SAPHO syndrome with an oral bisphosphonate. Rheumatol Int (2008) 1.27
Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg (2008) 1.27
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents. Cancer Invest (2009) 1.23
Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats. J Bone Miner Res (2010) 1.23
Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci (2011) 1.22
Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future. Int J Clin Oncol (2008) 1.21
Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Investig (2009) 1.20
Histone deacetylases in skeletal development and bone mass maintenance. Gene (2010) 1.16
Skeletal complications of breast cancer therapies. Clin Cancer Res (2006) 1.16
Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. J Oral Maxillofac Surg (2008) 1.15
Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review. Nat Rev Endocrinol (2010) 1.12
Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate. Oral Dis (2008) 1.10
Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Support Care Cancer (2009) 1.08
Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Clin Cases Miner Bone Metab (2007) 1.06
Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs. Osteoporos Int (2010) 1.06
Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer (2006) 1.05
Multiple myeloma. Curr Probl Cancer (2009) 1.04
Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig (2009) 1.03
Osteogenic potential of mandibular vs. long-bone marrow stromal cells. J Dent Res (2010) 1.02
Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice. J Bone Miner Res (2013) 1.02
Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporos Int (2008) 0.99
Stage 0 osteonecrosis of the jaw in a patient on denosumab. J Oral Maxillofac Surg (2014) 0.99
Mandibular necrosis in beagle dogs treated with bisphosphonates. Orthod Craniofac Res (2009) 0.99
Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res Clin Oncol (2010) 0.99
Effect of zoledronate on oral wound healing in rats. Clin Cancer Res (2010) 0.98
Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible. Orthod Craniofac Res (2010) 0.98
Treatment of painful bone metastases. Nat Rev Clin Oncol (2010) 0.98
Bisphosphonate-associated osteonecrosis of the jaw. Can Fam Physician (2008) 0.98
Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab (2009) 0.98
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin Oral Investig (2009) 0.98
Bone health and prostate cancer. Prostate Cancer Prostatic Dis (2009) 0.97
Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report. J Korean Assoc Oral Maxillofac Surg (2013) 0.96
Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab. Osteoporos Int (2013) 0.95
New and emerging therapies for bone metastases in genitourinary cancers. Eur Urol (2012) 0.95
The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study. Clin Oral Investig (2011) 0.95
RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease. J Bone Miner Res (2014) 0.94
Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws. Med Oral Patol Oral Cir Bucal (2012) 0.93
Bisphosphonates for malignancy-related bone disease: current status, future developments. Support Care Cancer (2006) 0.93
Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years? J Transl Med (2013) 0.92
Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing. Osteoporos Int (2013) 0.92
[Bisphosphonate-associated osteonecrosis of the jaw]. Mund Kiefer Gesichtschir (2006) 0.92
The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK. Osteoporos Int (2009) 0.91
Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid. HSS J (2008) 0.91
Bisphosphonates in Breast Cancer Patients with Bone Metastases. Breast Care (Basel) (2010) 0.91
Osteoporosis prevention and therapy: preserving and building strength through bone quality. Osteoporos Int (2006) 0.91
Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role. Arthritis Res Ther (2006) 0.90
Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature. Clin Oral Investig (2009) 0.90
An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence. J Bone Miner Metab (2011) 0.90
Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates. Drug Des Devel Ther (2011) 0.90
Phosphate: known and potential roles during development and regeneration of teeth and supporting structures. Birth Defects Res C Embryo Today (2008) 0.90
Intravenous bisphosphonates for postmenopausal osteoporosis. J Res Med Sci (2010) 0.90
Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy. J Cancer Res Clin Oncol (2009) 0.90
Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw. Ann N Y Acad Sci (2010) 0.89
Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review. J Oral Maxillofac Pathol (2012) 0.89
Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Spec Care Dentist (2010) 0.89
Oral bisphosphonate-associated osteonecrosis of maxillary bone: A review of 18 cases. J Clin Exp Dent (2014) 0.89
Bisphosphonates' antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay. Clin Oral Investig (2013) 0.89
Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia. Osteoporos Int (2009) 0.88
The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro. Head Face Med (2010) 0.88
Toll gates to periodontal host modulation and vaccine therapy. Periodontol 2000 (2009) 0.87
Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other. Semin Radiat Oncol (2010) 0.87
Legal liability in bisphosphonate-related osteonecrosis of the jaw. Br Dent J (2014) 0.87
Osteonecrosis of the jaw. Skeletal Radiol (2008) 0.87
Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects. Head Neck Pathol (2007) 0.87
Bisphosphonate-Related Osteonecrosis of the Jaw Bone: Radiological Pattern and the Potential Role of CBCT in Early Diagnosis. J Oral Maxillofac Res (2010) 0.87
Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws. Head Face Med (2012) 0.87
Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. Clin Oral Investig (2010) 0.86
Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci (2011) 0.86
Low magnitude mechanical signals mitigate osteopenia without compromising longevity in an aged murine model of spontaneous granulosa cell ovarian cancer. Bone (2012) 0.86
Estrogen regulation of apoptosis in osteoblasts. Physiol Behav (2009) 0.86
Bisphosphonate-related osteonecrosis of the jaw: clinical correlations with computerized tomography presentation. Clin Oral Investig (2009) 0.86
The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing. Odontology (2011) 0.86
Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis. Osteoporos Int (2013) 0.85
Treatment of bisphosphonate-induced osteonecrosis of the jaws with Nd:YAG laser biostimulation. Lasers Med Sci (2011) 0.85
Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J Periodontol (2013) 0.85
Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J Bone Metab (2014) 0.85
Influence of musculoskeletal conditions on oral health among older adults. Am J Public Health (2008) 0.84
Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws in an experimental rat model. Int J Med Sci (2011) 0.84
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg (2009) 8.79
Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 2.31
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res (2005) 1.75
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J (2009) 1.61
Gemcitabine-induced pulmonary toxicity: case report and review of the literature. Am J Clin Oncol (2002) 1.08
Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 1.01
Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management. Annu Rev Med (2009) 1.00
Clinical staging and prognostic markers in chronic lymphocytic leukemia. Hematol Oncol Clin North Am (2004) 0.98
EGFR expression in gallbladder carcinoma in North America. Int J Med Sci (2008) 0.88
Orbital lymphomas: a clinicopathologic study of a rare disease. Am J Med Sci (2006) 0.88
Diagnostic yield of bone marrow examination in fever of unknown origin. Am J Med (2003) 0.87
F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clin Nucl Med (2002) 0.85
Ten years of alendronate treatment for osteoporosis in postmenopausal women. N Engl J Med (2004) 0.78
Strength analysis of titanium and resorbable internal fixation in a mandibulotomy model. J Oral Maxillofac Surg (2005) 0.78
Utility of immunocytochemistry in diagnosing leptomeningeal metastases from an intrahepatic cholangiocarcinoma. Diagn Cytopathol (2013) 0.75
Emerging role of small ribonucleic acids in gastrointestinal tumors. Crit Rev Oncol Hematol (2010) 0.75
The role of monoclonal antibodies in stem cell transplantation. Semin Oncol (2004) 0.75